arrow
P

Paxton Bach

British Columbia Centre on Substance Use
H指数:21
被引数:1,937

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada

加拿大不列颠哥伦比亚省实施初期3年内,非处方兴奋剂使用者中处方的替代兴奋剂:考察达到的最大剂量与药物停用之间的关联

2026-08-300
OAAI
Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010–2020

比较不同时间点启动阿片类药物激动剂治疗减量对减量完成率和全因死亡率的影响:加拿大不列颠哥伦比亚省2010-2020年基于人群的回顾性目标试验模拟研究

2026-06-020
OAAI
Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series

苯二氮䓬类药物和阿片类药物滥用治疗药物在医院环境中用于苯二氮䓬污染芬太尼暴露者的戒断管理:一个病例系列

2026-06-010
OAAI
Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada

加拿大不列颠哥伦比亚省人口基础目标试验的模拟:尿液药物检测计划与阿片类药物激动剂治疗的比较效果

2025-08-310
OAAI
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
2024-12-030
PRE
Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials
2024-09-200
OA